Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD update on local anaesthetic shortages
Demand for the drug is particularly high in spring as it is used to provide local and regional anaesthesia for procedures such as calving and lambing.
Pronestesic currently available from suppliers 

The Veterinary Medicines Directorate (VMD) has responded to concerns about shortages of products containing the widely used local anaesthetic, procaine hydrochloride.

Some veterinary practices had reported a shortfall in supply due to unforeseen issues with the supply of raw materials, meaning they could only get hold of a fraction of the amount required.

Demand for the drug is particularly high in spring as it is used to provide local and regional anaesthesia for procedures such as calving and lambing, as well as Caesarians, castrations and dehorning of cattle.

In response to concerns from its members, BVA said it sought clarification from the VMD, which has confirmed that the product, Pronestesic, is currently available from suppliers. Normal UK availability for other products is expected to resume in May 2019.

Until then, vets are advised to use due diligence to source a product authorised in the UK, before considering importing an alternative medicine.

BVA president Simon Doherty said: “We’re pleased that VMD has issued some clarification to answer our concerns over procaine hydrochloride shortages... Although we had moved to get assurances sooner, we appreciate that there are formal routes for reporting and that the announcement of any shortage must be handled sensitively to avoid exacerbating the problem.

“VMD’s clarification is especially timely as this is a period of peak seasonal demand for these products. We will keep our members closely informed of any further developments.”

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.